Fasting Plasma Glucose and Its Relationship to Anthropometric Phenotype in Women Diagnosed with Gestational Diabetes According to IADPSG Criteria

被引:2
|
作者
Krystynik, Ondrej [1 ,2 ]
Macakova, Dominika [1 ,2 ]
Cibickova, Lubica [1 ,2 ]
Karasek, David [1 ,2 ]
机构
[1] Univ Hosp Olomouc, Palacky Univ Olomouc, Dept Internal Med 3,Nephrol Rheumatol & Endocrinol, Olomouc 77900, Czech Republic
[2] Palacky Univ Olomouc, Fac Med & Dent, Dept Internal Med 3,Nephrol Rheumatol & Endocrinol, Olomouc 77900, Czech Republic
来源
LIFE-BASEL | 2023年 / 13卷 / 01期
关键词
gestational diabetes; first-trimester fasting glucose; OGTT; gestational weight gain; perinatal outcomes; HYPERGLYCEMIA; PREGNANCY; MELLITUS; CLASSIFICATION;
D O I
10.3390/life13010137
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Gestational diabetes mellitus (GDM) is characterized by new-onset hyperglycemia in pregnancy. According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommendations, GDM may be diagnosed based on repeatedly increased fasting glucose levels in the first trimester, or later, the detection of increased fasting glucose and/or increased glucose levels during a 75 g oral glucose tolerance test (OGTT). The study aimed to assess whether differences may be found between women diagnosed with GDM by fasting glucose or glucose challenge tests in early or late pregnancy. Methods: The retrospective observational study enrolled 418 women diagnosed with GDM in accordance with the IADPSG criteria: early pregnancy fasting plasma glucose (FPG) >= 5.1 mmol/L; late pregnancy FPG >= 5.1 mmol/L (0 min) and/or postprandial plasma glucose (PPG) >= 10.0 mmol/L (60 min), PPG >= 8.5 mmol/L (120 min) 75 g OGTT. The analyses included anthropometric parameters at the beginning and during pregnancy, laboratory values of glycated hemoglobin, fructosamine, birth weight measures and the presence of neonatal complications. Results: There were significant differences in body weight (78.3 +/- 19.1; 74.0 +/- 16.7; 67.2 +/- 15.7 kg) and body mass index (BMI) (27.9 +/- 6.6; 26.4 +/- 5.8; 24.4 +/- 5.2 kg/m(2)) in early pregnancy. Differences were also found in gestational weight gain (9.3 +/- 6.8 vs. 12.4 +/- 6.9 vs. 11.1 +/- 4.7 kg) and the need for insulin therapy (14.7%; 7.1%; 4.0%). The study revealed no difference in the presence of neonatal complications but differences in birth weight (3372.2 +/- 552.2 vs. 3415.6 +/- 529.0 vs. 3199.0 +/- 560.5 g). Conclusions: Gestational diabetes, characterized by FPG >= 5.1 mmol/L in early pregnancy, is associated with higher body weight and BMI at the beginning of pregnancy as well as with a higher risk for insulin therapy and increased birth weight.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Glucose intolerance after a recent history of gestational diabetes based on the IADPSG criteria
    Katrien, Benhalima
    DevliegerRoland
    Johan, Verhaeghe
    Chantal, Mathieu
    ACTA CLINICA BELGICA, 2016, 71 : 10 - 10
  • [22] Glucose intolerance after a recent history of gestational diabetes based on the IADPSG criteria
    Jegers, K.
    Devlieger, R.
    Verhaeghe, J.
    Mathieu, C.
    Benhalima, K.
    DIABETOLOGIA, 2016, 59 : S454 - S454
  • [23] Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria
    Agarwal, M. M.
    Dhatt, G. S.
    Punnose, J.
    DIABETIC MEDICINE, 2006, 23 (12) : 1319 - 1326
  • [24] Gestational diabetes mellitus among Nordic Caucasian women: Prevalence and risk factors according to WHO and simplified IADPSG criteria
    Helseth, Ragnhild
    Salvesen, Oyvind
    Stafne, Signe N.
    Morkved, Siv
    Salvesen, Kjell A.
    Carlsen, Sven M.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (07): : 620 - 628
  • [25] ATLANTIC DIP: Insulin Therapy for Women with IADPSG-Diagnosed Gestational Diabetes Mellitus
    Bogdanet, D.
    Egan, A. M.
    Kgosidialwa, O.
    Kirwan, B.
    Carmody, L.
    Dunne, F. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S434 - S434
  • [26] Gestational diabetes mellitus: Screening with fasting plasma glucose
    Agarwal, Mukesh M.
    WORLD JOURNAL OF DIABETES, 2016, 7 (14) : 279 - 289
  • [27] ATLANTIC DIP: insulin therapy for women with IADPSG-diagnosed gestational diabetes mellitus
    Bogdanet, D.
    Egan, A. M.
    Kirwan, B.
    Carmody, L.
    Dunne, F. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 388 - 389
  • [28] Using fasting plasma glucose to identify women with gestational diabetes at low risk of complications
    McIntyre, H.
    Gibbons, K. S.
    Sacks, D. A.
    Madsen, L. R.
    Ma, R. C. W.
    Tam, W. H.
    Catalano, P. M.
    DIABETOLOGIA, 2019, 62 : S79 - S79
  • [29] Inadequacy of fasting plasma glucose to diagnose gestational diabetes mellitus in Asian Indian women
    Balaji, V.
    Balaji, Madhuri
    Anjalakshi, C.
    Cynthia, A.
    Arthi, T.
    Seshiah, V.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (01) : E21 - E23
  • [30] Comparative study of perinatal outcomes between pregnant women with gestational diabetes mellitus diagnosed by the new IADPSG and the old ADA criteria
    Phelipe Guimarães de Ornellas
    Luana Verztman Bagdadi
    Zuliana Bonde Almeida
    Priscila de Almeida Lago
    Ana Luíza Campanholo
    Joana Rodrigues Dantas
    Marcus Miranda dos Santos Oliveira
    Melanie Rodacki
    Lenita Zajdenverg
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):